Latest Synlait News

Synlait’s operational recovery gathered pace in the second half, but the NZX-listed dairy processor still reported a NZ$75.4 million FY26 loss and negative operating cash flow. KPMG flagged a material uncertainty over going concern as the company prepares to refinance facilities due in 2027.

Synlait Milk anticipates a modest improvement in underlying EBITDA for FY26 but expects a substantial net loss after tax, reflecting ongoing operational challenges and a tough first half.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

Synlait Milk has locked in a NZ$320 million refinancing package with a broad banking syndicate and replaced its $130 million shareholder loan, while shifting its financial year-end to December to match its major shareholder.

Synlait Milk is progressing a key refinancing of its senior bank facilities due June 2026 and plans to replace a $130 million shareholder loan with a two-year term facility. The company reports a preliminary $12 million net loss for the first four months of 2026 amid operational headwinds and asset sales.

Synlait Milk is on track to refinance its senior bank facilities by June 30, 2026, replacing a $130 million shareholder loan from Bright Dairy with a new two-year loan. The company reported a preliminary net loss of $12 million for the first four months of 2026, reflecting operational headwinds and the recent North Island asset sale.

Synlait Milk announces CEO Richard Wyeth's resignation effective end of June, with Acting CEO Leon Fung appointed immediately to steer through ongoing operational challenges.

Synlait Milk has obtained waivers from its syndicated banks on key financial covenants for the quarter ending April 2026, reflecting ongoing operational and market challenges.

Synlait Milk Limited confirms extended product release times and supply chain disruptions following The a2 Milk Company's update on its China infant formula business. The company maintains no FY26 guidance amid persistent industry risks.

The a2 Milk Company faces significant supply chain disruptions in China, dampening its infant formula sales and forcing a downgrade of its FY26 financial outlook despite robust demand.

The a2 Milk Company reports robust demand for its infant formula in China but warns that supply chain disruptions, linked partly to the Middle East conflict, will dampen sales and margins in FY26.